ReviewCancers2026

Genomic Biomarkers for First-Line Treatment Selection in Metastatic Pancreatic Ductal Adenocarcinoma: A Narrative Review.

Anushareddy Muddasani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.